Skip to main content

Allan Douglas Kirk, MD, PhD

David C. Sabiston, Jr. Professor of Surgery
Campus Mail: 3704, Durham, NC 27710
Email: allan.kirk@duke.edu

Education and Training

  • Fellow, Multi Organ Transplantation, University of Wisconsin at Madison, 1995 - 1997
  • Chief Resident, Surgery, Duke University, 1994 - 1995
  • Senior Resident, Surgery, Duke University, 1992 - 1994
  • Research Fellow, Surgery, Duke University, 1989 - 1992
  • Intern & Junior Resident, Surgery, Duke University, 1987 - 1989
  • Ph.D., Duke University, 1992
  • M.D., Duke University School of Medicine, 1987
  • B.S., Old Dominion University, 1983

Selected Grants and Awards

Selected Publications

Xu, H, Perez, SD, Cheeseman, J, Mehta, AK, and Kirk, AD. "The Allo- and Viral-Specific Immunosuppressive Effect of Belatacept, but Not Tacrolimus, Attenuates With Progressive T Cell Maturation." American Journal of Transplantation 14, no. 2 (February 2014): 319-332.

Full Text

Lo, DJ, Kaplan, B, and Kirk, AD. "Biomarkers for kidney transplant rejection." Nature Reviews Nephrology 10, no. 4 (January 21, 2014): 215-225.

Full Text

Lowe, MC, Badell, IR, Turner, AP, Thompson, PW, Leopardi, FV, Strobert, EA, Larsen, CP, and Kirk, AD. "Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy." American Journal of Transplantation 13, no. 2 (February 2013): 312-319.

Full Text

Lo, DJ, Anderson, DJ, Weaver, TA, Leopardi, F, Song, M, Farris, AB, Strobert, EA, Jenkins, J, Turgeon, NA, Mehta, AK, Larsen, CP, and Kirk, AD. "Belatacept and Sirolimus Prolong Nonhuman Primate Renal Allograft Survival Without a Requirement for Memory T Cell Depletion." American Journal of Transplantation 13, no. 2 (February 2013): 320-328.

Full Text

Charafeddine, AH, Kim, EJ, Maynard, DM, Yi, H, Weaver, TA, Gunay-Aygun, M, Russell, M, Gahl, WA, and Kirk, AD. "Platelet-Derived CD154: Ultrastructural Localization and Clinical Correlation in Organ Transplantation." American Journal of Transplantation 12, no. 11 (November 2012): 3143-3151.

Full Text

Thompson, P, Badell, IR, Lowe, M, Turner, A, Cano, J, Avila, J, Azimzadeh, A, Cheng, X, Pierson III, RN, Johnson, B, Robertson, J, Song, M, Leopardi, F, Strobert, E, Korbutt, G, Rayat, G, Rajotte, R, Larsen, CP, and Kirk, AD. "Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway-Sparing Regimens Promote Xenograft Survival." American Journal of Transplantation 12, no. 7 (July 2012): 1765-1775.

Full Text

Lo, DJ, Weaver, TA, Stempora, L, Mehta, AK, Ford, ML, Larsen, CP, and Kirk, AD. "Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression." American Journal of Transplantation 11, no. 1 (January 2011): 22-33.

Full Text

Newell, KA, Asare, A, Kirk, AD, Gisler, TD, Bourcier, K, Suthanthiran, M, Burlingham, WJ, Marks, WH, Sanz, I, Lechler, RI, Hernandez-Fuentes, MP, Turka, LA, and Seyfert-Margolis, VL. "Identification of a B cell signature associated with renal transplant tolerance in humans." Journal of Clinical Investigation 120, no. 6 (June 1, 2010): 1836-1847.

Full Text

Pages